Prestige Consumer Hlthcr Price Target Maintained With a $95.00/Share by DA Davidson
D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
D.A. Davidson Sticks to Their Buy Rating for Prestige Consumer Healthcare (PBH)
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Raises Target Price to $93
Premium Brands Hldgs Analyst Ratings
Prestige Consumer Hlthcr Price Target Raised to $76.00/Share From $70.00 by Jefferies
Prestige Consumer Analyst Ratings
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $81
D.A. Davidson Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $95
D.A. Davidson Remains a Buy on Prestige Consumer Healthcare (PBH)
DA Davidson Maintains Buy on Prestige Consumer, Maintains $93 Price Target
Prestige Consumer Analyst Ratings
Prestige Consumer Analyst Ratings
DA Davidson Upgrades Prestige Consumer Healthcare to Buy From Neutral, Adjusts Price Target to $93 From $65
Canadian Investment Banking Group: Maintaining the Prestige Consumer (PBH.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $80.00 to $80.00.
Prestige Consumer Analyst Ratings
DA Davidson: Maintaining the Prestige Consumer (PBH.US) rating, adjusted from neutral to neutral, and adjusted the target price from $65.00 to $65.00.
Prestige Consumer Analyst Ratings
DA Davidson Maintains Neutral on Prestige Consumer, Maintains $65 Price Target